United States - English - NLM (National Library of Medicine)

wockhardt usa, inc. - triprolidine hydrochloride (unii: yan7r5l890) (triprolidine - unii:2l8t9s52qm), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520) - syrup - 1.25 mg in 5 ml - pseudodine™ c cough syrup is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. pseudodine™ c cough syrup is contraindicated under the following conditions: this drug should not be used in newborn or premature infants. antihistamines should not be used to treat lower respiratory tract symptoms, including asthma. (1) codeine phosphate or other narcotics; (2) triprolidine hydrochloride or other antihistamines of similar chemical structure; or (3) sympathomimetic amines, including pseudoephedrine. sympathomimetic amines are contraindicated in patients with severe hypertension, severe coronary artery disease and in patients on monoamine oxidase (mao) inhibitor therapy (see precautions, drug interactions ). like other medications containing a narcotic, pseudodine™ c cough syrup is controlled by the drug enforcement administration. it is classified under schedule v. codeine can produce drug dependence of the morphine typ

Malta - English - Medicines Authority

glaxo wellcome uk limited - triprolidine hydrochloride; pseudoephedrine hydrochloride - oral solution - triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo wellcome uk limited - triprolidine hydrochloride; pseudoephedrine hydrochloride - tablet - triprolidine hydrochloride 2.5 mg; pseudoephedrine hydrochloride 60 mg - nasal preparations

Malta - English - Medicines Authority

glaxo wellcome uk limited - triprolidine hydrochloride; pseudoephedrine hydrochloride; dextromethorphan hydrobromide - oral solution - triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml; dextromethorphan hydrobromide 10 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo wellcome uk limited - triprolidine hydrochloride; pseudoephedrine hydrochloride - oral solution - triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - pseudoephedrine hydrochloride ; dextromethorphan hydrobromide ; triprolidine hydrochloride - syrup - 30/10/1.25 milligram - pseudoephedrine, combinations

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - pseudoephedrine hydrochloride; triprolidine hydrochloride -

Malta - English - Medicines Authority

glaxo wellcome uk limited - guaifenesin; triprolidine hydrochloride; pseudoephedrine hydrochloride - oral solution - guaifenesin 100 mg/5ml; triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo wellcome uk limited - dextromethorphan hydrobromide; triprolidine hydrochloride; pseudoephedrine hydrochloride - oral solution - dextromethorphan hydrobromide 10 mg/5ml; triprolidine hydrochloride 1.25 mg/5ml; pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - triprolidine hydrochloride, pseudoephedrine hydrochloride - oral solution - triprolidine hydrochloride 1.25 mg/5ml pseudoephedrine hydrochloride 30 mg/5ml - nasal preparations